Benzinga | Sep 27, 2021 05:55AM EDT

SVB Leerink Initiates Coverage On Amedisys with Market Perform Rating, Announces Price Target of $170

SVB Leerink analyst Whit Mayo initiates coverage on Amedisys (NASDAQ:AMED) with a Market Perform rating and announces Price Target of $170.